Dexetimide: Clinical Trials

8 trials of Dexetimide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 unknown, 1 withdrawn. 8 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 4, Terminated 2, Unknown 1, Withdrawn 1
Phase 23Completed 1, Terminated 1, Unknown 1

Follow Dexetimide: new trials by email Literature Review of Dexetimide trials Research Report on Dexetimide

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study
Escitalopram, Brexpiprazole - Major Depressive Disorder
Phase 3CompletedUniversity Health Network, Toronto12019-12-232023-03-02
The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
Escitalopram, placebo - GBM, Depression
Phase 2 / Phase 3UnknownTel-Aviv Sourasky Medical Center1002015-12-012015-12-07
Canadian Biomarker Integration Network for Depression Study
escitalopram, aripiprazole - Major Depressive Disorder
Phase 3CompletedUniversity Health Network, Toronto2112012-04-232018-05-11
Antidepressants and Bone Mineral Density
sertraline, citalopram, venlafaxine - Bone Mineral Density Quantitative Trait Locus 7
Phase 3CompletedGuiyang Medical University2032012-03-012014-07-01
Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
Escitalopram, Bupropion XL - Bipolar I Disorder
Phase 3TerminatedUniversity of British Columbia2372010-11-012025-05-15
EScitalopram PIndolol ONset of Action
escitalopram, pindolol, escitalopram - Unipolar Depression
Phase 2 / Phase 3TerminatedMarkus KOSEL182010-10-012015-05-27
Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression
S-citalopram, Cognitive behavioral therapy (CBT), TRODAT-1 single photon emission computed tomographic (SPECT) imaging - Depression
Phase 2 / Phase 3CompletedUniversity of Pennsylvania662005-10-012020-04-16
Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
escitalopram - Anxiety, COPD
Phase 3WithdrawnHull University Teaching Hospitals NHS Trust2017-03-29

Conditions studied

Depression (3)  ·  Depressive Disorder, Major (2)  ·  Anxiety Disorders (1)  ·  Depressive Disorder (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

University Health Network, Toronto (2)  ·  Guiyang Medical University (1)  ·  Hull University Teaching Hospitals NHS Trust (1)  ·  Markus KOSEL (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  University of British Columbia (1)  ·  University of Pennsylvania (1)

Countries

Canada (3)  ·  Israel (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

A. Daigneault, Dr. (1)  ·  A. Ravindran, Dr. (1)  ·  A. Schaffer, Dr. (1)  ·  A.V. Mysore, Dr. (1)  ·  Alyn H Morice, Professor (1)  ·  B. Frey, Dr. (1)  ·  J. Y. Reddy, Dr. (1)  ·  Jay D. Amsterdam, MD (1)  ·  Lakshmi Yatham, Dr. (1)  ·  M.S. Reddy, Dr. (1)  ·  Markus Kosel, MD-PhD (1)  ·  P. Cervantes, Dr. (1)  ·  P.S. Sharma, Dr. (1)  ·  R. Milev, Dr. (1)  ·  Rachel Grossman, MD (1)

Results publications

PMID 30840787, PMID 31471185, PMID 32349119, PMID 32558407, PMID 33296696, PMID 33520402, PMID 33683582, PMID 33860922, PMID 34008342, PMID 34229186, PMID 34416758, PMID 35023065, PMID 35546043, PMID 37530824, PMID 37796764, PMID 37967350, PMID 38128154

NIH funding

R34MH070753 (1)